Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dr. Reddy’s Launches Debiopharm’s Pamorelin® LA in India

Published: Friday, December 07, 2012
Last Updated: Friday, December 07, 2012
Bookmark and Share
Pamorelin® LA for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Debiopharm Group™ (Debiopharm) has announced that Dr. Reddy’s Laboratories Ltd. has launched Pamorelin® LA in India for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer on December 3.

Under the terms of the agreement, Dr. Reddy’s acquires exclusive marketing and sales rights for Pamorelin® LA Depot in India.

The product is exported in bulk from Debio Recherche Pharmaceutique (Debio R.P.) to Dr. Reddy’s.

Pamorelin® LA will be made available primarily to urologists and oncologists across India.

‘We recognize the need for prostate cancer treatment in India and are thrilled to have the opportunity to bring Pamorelin® LA to Indian patients’, said Rolland-Yves Mauvernay, President and founder of Debiopharm Group™.

Mauvernay continued, ‘This major step enables us to implement our strategy in one of the most important markets in Asia. This is only the logical continuation to a harmonious working relationship shared with Dr. Reddy’s over the years.’

Dr. Reddy’s and Debiopharm share the same vision to bring high-quality and safe ethical products to the highest number of patients suffering from serious diseases in India.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Debiopharm Group™ Presents The ‘JCA Mauvernay Award 2013’
Doctors Kitabayashi and Yano will receive awards during the General Assembly of the 72nd Annual Conference of the JCA in Yokohama.
Tuesday, October 08, 2013
Oncotest and Debiopharm Announce a Successful Partnership
Successful completion of first biomarker projects at Oncotest.
Wednesday, April 24, 2013
Curis and Debiopharm Announce Initiation of Phase I-II Clinical Study of HSP90 Inhibitor
Study to test Debio 0932 in patients with advanced non-small cell lung cancer.
Friday, August 17, 2012
Debiopharm and Vifor Pharma Sign an Exclusive Agreement
Distribution and commercialization of Pamorelin® LA in Switzerland.
Monday, May 21, 2012
Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Changing the Biological Data Visualisation World
Scientists at TGAC, alongside European partners, have created a cutting-edge, open source community for the life sciences.
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!